Harshabad Singh, MD, is a physician-scientist and medical oncologist specializing in gastrointestinal oncology. He serves as an Assistant Professor at Massachusetts General Hospital and Program Director for Hepatobiliary and Pancreas Oncology at the Mass General Brigham Cancer Institute. He also holds faculty appointments at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Harvard Medical School. Clinically, Dr. Singh focuses on gastrointestinal oncology, hepatobiliary oncology, and pancreas oncology. His translational research spans cancer epigenetics, biomarker discovery and early detection, and therapeutic resistance and response prediction, with the goal of accelerating laboratory insights to patient care. A recognized leader, he has been honored with the Damon Runyon Physician-Scientist Training Award, the Senior Resident Excellence in Teaching Award, and designation as a Team Perry PMC Fellow. Dr. Singh earned his medical degree from Government Medical College and Hospital in Chandigarh, completed internal medicine residency and served as chief resident at Massachusetts General Hospital, and completed a medical oncology fellowship at Dana-Farber Cancer Institute.
Assistant Professor
Medical School
2004 – 2009
Residency
2012 – 2015
Fellowship
2016 – 2019